Ajinomoto Bio-Pharma Services Receives FDA Approval for High Potency Fill Line
SAN DIEGO, April 19, 2023 /PRNewswire/ — Ajinomoto Bio-Pharma Services (“Aji Bio-Pharma”), a leading provider of biopharmaceutical contract development and
Read MoreSAN DIEGO, April 19, 2023 /PRNewswire/ — Ajinomoto Bio-Pharma Services (“Aji Bio-Pharma”), a leading provider of biopharmaceutical contract development and
Read MoreDEKRA expands the Management Board Two new Board Members to join DEKRA SE: Petra Finke (55) to become Chief Digitalization
Read More